These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21815836)

  • 1. The oxidant/antioxidant status and cell death mode in oral squamous cell carcinoma.
    Barut O; Vural P; Şirin Ş; Aydin S; Dizdar Y
    Acta Odontol Scand; 2012 Jul; 70(4):303-8. PubMed ID: 21815836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients.
    Gokul S; Patil VS; Jailkhani R; Hallikeri K; Kattappagari KK
    Oral Dis; 2010 Jan; 16(1):29-33. PubMed ID: 19656315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress status and DNA damage in saliva of human subjects with oral lichen planus and oral squamous cell carcinoma.
    Agha-Hosseini F; Mirzaii-Dizgah I; Farmanbar N; Abdollahi M
    J Oral Pathol Med; 2012 Nov; 41(10):736-40. PubMed ID: 22582895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma.
    Korde SD; Basak A; Chaudhary M; Goyal M; Vagga A
    Oncology; 2011; 80(5-6):382-9. PubMed ID: 21829039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
    Malik UU; Siddiqui IA; Hashim Z; Zarina S
    Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
    Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
    Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
    Bilici A; Ustaalioglu BB; Ercan S; Orcun A; Seker M; Salepci T; Gumus M
    Cancer Chemother Pharmacol; 2011 Aug; 68(2):309-16. PubMed ID: 20967544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilization of cytokeratin-based biomarkers for pharmacodynamic studies.
    Linder S; Olofsson MH; Herrmann R; Ulukaya E
    Expert Rev Mol Diagn; 2010 Apr; 10(3):353-9. PubMed ID: 20370591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH; Lin YS; Lin CC; Yang YH; Ho YP; Tsai CC
    J Oral Pathol Med; 2004 Nov; 33(10):589-94. PubMed ID: 15482324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of malignant transformation: a pilot study.
    Nayyar AS; Khan M
    J Cancer Res Ther; 2012; 8(2):277-81. PubMed ID: 22842375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidant-antioxidant status in Indian patients with carcinoma of posterior one-third of tongue.
    Sharma M; Rajappa M; Kumar G; Sharma A
    Cancer Biomark; 2009; 5(6):253-60. PubMed ID: 20037201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.
    Likidlilid A; Patchanans N; Peerapatdit T; Sriratanasathavorn C
    J Med Assoc Thai; 2010 Jun; 93(6):682-93. PubMed ID: 20572373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of enzymatic and non-enzymatic antioxidant status and biomarkers of oxidative stress in saliva of patients with oral squamous cell carcinoma and oral leukoplakia: a pilot study.
    Babiuch K; Bednarczyk A; Gawlik K; Pawlica-Gosiewska D; Kęsek B; Darczuk D; Stępień P; Chomyszyn-Gajewska M; Kaczmarzyk T
    Acta Odontol Scand; 2019 Aug; 77(6):408-418. PubMed ID: 30857448
    [No Abstract]   [Full Text] [Related]  

  • 15. Salivary analysis in oral cancer patients: DNA and protein oxidation, reactive nitrogen species, and antioxidant profile.
    Bahar G; Feinmesser R; Shpitzer T; Popovtzer A; Nagler RM
    Cancer; 2007 Jan; 109(1):54-9. PubMed ID: 17099862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione, ascorbic acid and antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell carcinoma.
    Fiaschi AI; Cozzolino A; Ruggiero G; Giorgi G
    Eur Rev Med Pharmacol Sci; 2005; 9(6):361-7. PubMed ID: 16479741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant enzyme levels in pathogenesis of oral squamous cell carcinoma (OSCC).
    Huo W; Li ZM; Pan XY; Bao YM; An LJ
    Drug Res (Stuttg); 2014 Nov; 64(11):629-32. PubMed ID: 24623030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic and non-enzymatic antioxidant status in stage (III) human oral squamous cell carcinoma and treated with radical radio therapy: influence of selenium supplementation.
    Elango N; Samuel S; Chinnakkannu P
    Clin Chim Acta; 2006 Nov; 373(1-2):92-8. PubMed ID: 16831410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trace metals and total antioxidant potential in head and neck cancer patients.
    Akinmoladun VI; Owotade FJ; Olusanya AA
    Ann Afr Med; 2013; 12(2):131-4. PubMed ID: 23713022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.
    Ausch C; Buxhofer-Ausch V; Olszewski U; Hinterberger W; Ogris E; Schiessel R; Hamilton G
    Eur J Surg Oncol; 2009 Nov; 35(11):1164-8. PubMed ID: 19254831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.